![COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7104e2_IncidenceDeathRatesOmicron_IMAGE_21Jan22_1200x627.jpg?_=64029)
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR
![Omicron booster: UK becomes first nation to approve vaccine that targets two Covid-19 variants | CNN Omicron booster: UK becomes first nation to approve vaccine that targets two Covid-19 variants | CNN](https://media.cnn.com/api/v1/images/stellar/prod/220815081045-moderna-covid-booster-omicron-variant.jpg?c=original)
Omicron booster: UK becomes first nation to approve vaccine that targets two Covid-19 variants | CNN
![Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland | The University of Edinburgh Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland | The University of Edinburgh](https://www.ed.ac.uk/sites/default/files/styles/landscape_breakpoints_theme_uoe_mobile_1x/public/thumbnails/image/v.6_omicron.png?itok=ZFbrm-WP)
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland | The University of Edinburgh
![Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01705-6/MediaObjects/41591_2022_1705_Fig1_HTML.png)
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine
![COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents - eBioMedicine COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents - eBioMedicine](https://www.thelancet.com/cms/asset/be95fd01-303d-485d-806b-6d494baf486e/gr1.jpg)